BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7965265)

  • 1. Cough with angiotensin converting enzyme inhibitors: how much of a problem?
    Fletcher AE; Palmer AJ; Bulpitt CJ
    J Hypertens Suppl; 1994 Jul; 12(2):S43-7. PubMed ID: 7965265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS; Nicholls MG
    Br J Clin Pharmacol; 1995 Aug; 40(2):141-4. PubMed ID: 8562296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
    J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study.
    Gilchrist NL; Richards AM; March R; Nicholls MG
    J Hum Hypertens; 1989 Dec; 3(6):451-5. PubMed ID: 2691690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
    Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
    J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC; Breeze E; Fletcher AE
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cough with angiotensin converting-enzyme inhibitors.
    Hood S; Nicholls MG; Gilchrist NL
    N Z Med J; 1987 Jan; 100(816):6-7. PubMed ID: 3027630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromolyn sodium for ACE inhibitor-induced cough.
    Allen TL; Gora-Harper ML
    Ann Pharmacother; 1997 Jun; 31(6):773-5. PubMed ID: 9184721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of cough during therapy with ACE inhibitors in Greek hypertensives.
    Efstratopoulos AD; Meikopoulos M; Voyaki S
    J Hum Hypertens; 1993 Dec; 7(6):607-9. PubMed ID: 8114058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Fisman EZ; Grossman E; Motro M; Tenenbaum A
    J Hum Hypertens; 2002 Jun; 16(6):379-83. PubMed ID: 12037691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway responsiveness and cough induced by angiotensin converting enzyme inhibition.
    Overlack A; Müller B; Schmidt L; Scheid ML; Müller M; Stumpe KO
    J Hum Hypertens; 1992 Oct; 6(5):387-92. PubMed ID: 1464896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study.
    Fogari R; Zoppi A; Tettamanti F; Malamani GD; Tinelli C; Salvetti A
    J Cardiovasc Pharmacol; 1992 May; 19(5):670-3. PubMed ID: 1381763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects in 28 patients treated with angiotensin converting enzyme (ACE) inhibitor in arterial hypertension in general practice].
    Heldgaard PE
    Ugeskr Laeger; 1990 Aug; 152(34):2427-8. PubMed ID: 2402813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cough, bronchoconstriction and bronchial hyperreactivity in relation to treatment with angiotensin-converting enzyme].
    Szmidt M; Minc P
    Pol Merkur Lekarski; 1999 May; 6(35):281-5. PubMed ID: 10437403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.
    Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
    J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between polymorphism of angiotensin converting enzyme gene and cough caused by angiotensin converting enzyme inhibitors].
    Yang SM; He QY; Miao YD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):203-5. PubMed ID: 12901825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.